Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, and have signed a strategic agreement to renew a five-year manufacturing partnership. Bora purchased the Mississauga facility from GSK in 2020. This renewed collaboration reinforces the long-standing relationship between the two companies…
Astellas Pharma Inc. and Vir Biotechnology, Inc. announced they have entered into a global strategic collaboration to advance VIR-5500, an investigational PRO-XTEN® dual-masked CD3 T-cell engager (TCE) targeting PSMA for the treatment of prostate cancer. The collaboration aims to accelerate the development of VIR-5500…
Danaher Corporation, a global science and technology innovator, announced that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, …
The Jackson Laboratory–New York Stem Cell Foundation Collaborative announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of neurodegenerative disease, including Alzheimer's disease. The collaboration reflects a strategic focus that brings together human stem cell r…
Scinai Immunotherapeutics Ltd., a biopharmaceutical company developing inflammation and immunology (I&I) therapeutics and operating a growing CDMO business, announced that it has acquired 100% of the shares of Recipharm Israel Ltd., which operates Recipharm's site in Yavne, Israel, and entered into a long-term str…
OPTEL, a global leader in track-and-trace solutions, and Techno Service, Egypt's premier industrial systems expert, announced an exclusive partnership. The collaboration delivers a fully localized, end-to-end serialization and aggregation solution for pharmaceutical manufacturers and Third-Party Logistics (3PL) provid…
QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd., to expand QuidelOrtho's global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient solutions across select markets outside the United States. The agreement provides QuidelOrt…
SSI Diagnostica Group, a global company specializing in testing solutions for infectious diseases, has announced the acquisition of InDevR, a Colorado-based provider of advanced multiplexed solutions for vaccine testing and quality control. The addition strengthens SSID Group’s leadership in pneumococcal vaccine QC te…
Agilent Technologies, Inc. and Virscidian, LLC announced an expanded collaboration to enhance interoperability between Agilent OpenLab CDS and Virscidian Analytical Studio. The solution enables scientists to seamlessly access chromatography data and orchestrate high-throughput workflows, including purification. It de…
BioLife Solutions, Inc., a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain cytokine and growth factor products manufactured by Qkine …
Page 16 of 37